Stock Taper
SCREENER COMPARE ANY 2 STOCKS
STTK
SHATTUCK LABS, INC.
NASDAQ
$7.04
▼ DOWN 7.97% (-0.61)

KEY STATISTICS

Market Cap$636.22 M
52w High$8.33
52w Low$0.98
Dividend Yield—
Frequency—
P/E-13.80
Volume623.13K
Shares Out.90.37M

COMPANY

LEADERSHIP

Taylor H. Schreiber
CHIEF EXECUTIVE
Taylor H. Schreiber

COMPENSATION 2026

Salary$565,600
Stock Awards$0
Incentive Plan Pay$296,940
All Other Comp.$13,692
Total$1,532,763

ABOUT

SECTOR
Healthcare
WENT PUBLIC
October 9, 2020
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
40

PRICE TARGET

Target High$18.00
Target Low$7.00
Target Median$14.00
Target Consensus$13.20

UPCOMING EARNINGS

DateNov 10, 2026
DayTuesday
Rev. Est.$37.50K
NOV
10
TUE

PRICE

$7.04 ▼ DOWN 7.97% (−$0.61)
$7.00$7.20$7.40$7.609:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM7.04

About Shattuck Labs, Inc.

https://www.shattucklabs.com ↗

Shattuck Labs, Inc., a clinical-stage biotech based in Austin, Texas, develops cancer and autoimmune therapeutics, with lead candidates SL-172154 and SL-279252 in Phase 1 trials for various cancers.

INDUSTRY

Biotechnology

A PRODUCT SHATTUCK LABS, INC. IS KNOWN FOR

SL-325
SL-325

SL-325 is Shattuck Labs' lead monoclonal antibody in Phase I clinical trials, developed to treat inflammatory and immune-mediated diseases.

COMPETITORS

COMPETITOR
ANNX COMPARE
ARGX COMPARE
KYMR COMPARE
ROIV COMPARE

Revenue by Products

IconPRODUCTQ3-2024Q4-2024Q3-2025Q4-2025
License$3M $0 ▼$1M ▲$2.4M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
60
LISTED HERE
14
RANKED BY POSITION SIZE
VTS.AX
0.00% · 2.4M
XSU.TO
0.02% · 1.6M
FESM
0.04% · 371.9K
R2US.L
0.01% · 114.2K
GSSC
0.06% · 82.1K
XRS2.F
0.01% · 56.1K
CN
CNCR
3.23% · 54.0K
DFAS
0.00% · 49.6K
PRFZ
0.01% · 31.9K
RSSL
0.01% · 29.0K
AVSC
0.01% · 21.2K
TXS
0.08% · 4.2K
URTY
0.01% · 2.5K
TNXT
0.09% · 2.1K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
50.68%
HOLDERS
101
TOP 12 OF 101 · RANKED BY POSITION SIZE
T. Rowe Price Investment Management, Inc.
9.9M sh · $63.44M
Orbimed Advisors LLC
6.3M sh · $23.02M
Adage Capital Partners Gp, L.L.C.
6.3M sh · $15.07M
Redmile Group, LLC
5.5M sh · $35.62M
Prosight Management, LP
5.5M sh · $13.03M
Blackrock Inc.
2.5M sh · $9.55M
Vanguard Group Inc
2.4M sh · $8.68M
Price T Rowe Associates Inc /Md/
1.9M sh · $7.03M
683 Capital Management, LLC
1.5M sh · $3.66M
Clark Estates Inc/Ny
1.5M sh · $9.49M
Pinnacle Associates Ltd
1.4M sh · $3.32M
Abrdn Plc
1.2M sh · $7.45M

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book2
Overall Score2

INSIDER TRADES

★
OFFICER: CHIEF TECHNICAL OFFICER
Shukla Abhinav A.
Sale · 12.2K shares
2026-07-06
★
OFFICER: CHIEF TECHNICAL OFFICER
Shukla Abhinav A.
Purchase · 12.2K shares
2026-07-06
★
OFFICER: CHIEF TECHNICAL OFFICER
Shukla Abhinav A.
Sale · 410 shares
2026-07-02
★
OFFICER: CHIEF TECHNICAL OFFICER
Shukla Abhinav A.
Purchase · 410 shares
2026-07-02

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 3
OUTPERFORM 1
4 GRADES IN THE LAST 12 MONTHS
HC Wainwright & Co. BUY Citigroup BUY Needham BUY Wedbush OUTPERFORM

SECTORS PEERS

PEERPRICE
ARTV$11.09COMPARE
OVID$2.80COMPARE
IFRX$2.23COMPARE
ZNTL$3.80COMPARE
STRO$20.45COMPARE
CNTB$2.23COMPARE
KLRS$4.03COMPARE
IMA$5.34COMPARE